Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase I/II Study of Samarium 153 as Part of a Double (Sequential) Autologous Bone Marrow Transplant (ABMT) for Patients With Stage IV Breast Cancer

NCT00003086 is registered in ClinicalTrials.gov with Louisiana State University Health Sciences Center Shreveport as lead sponsor.

NCT NCT00003086
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00003086 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase I/II Study of Samarium 153 as Part of a Double (Sequential) Autologous Bone Marrow Transplant (ABMT) for Patients With Stage IV Breast Cancer
Lead sponsor
Louisiana State University Health Sciences Center Shreveport
Phase
Phase 1/2
Overall status
Terminated
Start date
March 31, 1997
Completion date
January 28, 2001
Enrollment
12 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer